Case Study 1 — The Affordable Care Act's Fifteen-Year Trajectory

Why this case

The ACA is the running legislative example throughout this textbook. We have already followed its bill path through Congress (Ch. 9), its bureaucratic implementation (Ch. 11), and its constitutional test in NFIB v. Sebelius (Ch. 14). This case study brings the threads together as a fifteen-year political and policy trajectory: from the pre-2010 dysfunction it was designed to address, through passage and survival, through implementation and recalibration, to the politically settled but still-contested status it occupies in 2026.

The case is worth studying not because the ACA is the most ambitious or most successful piece of social legislation in modern American history (it is neither — the Great Society was more ambitious, and the empirical record is more mixed than partisans on either side claim). It is worth studying because it shows how American a major reform looks: the layered design choices, the coalition compromises, the judicial reshaping, the political near-death and recovery, and the eventual settlement at a place neither original advocates nor original opponents wanted.

Stage 1: The pre-ACA market (early 2000s)

The American health-insurance system in 2008 had a documented set of problems. The uninsured population stood at roughly 47 million people. Pre-existing-condition exclusions in the individual market meant that anyone with a chronic illness — diabetes, prior cancer, mental-health diagnosis, even pregnancy in some states — could be denied coverage outright or charged unaffordable premiums. The individual market was a small, dysfunctional pool — about 12 million people — with adverse-selection problems that drove premiums up year over year. Job lock — workers staying in jobs they would otherwise leave to keep employer-sponsored coverage — was widespread. Medical bankruptcy was the leading cause of personal bankruptcy filings, accounting (depending on the methodology) for 40 to 60 percent of all filings.

Reform proposals had been advanced from across the spectrum. Bill Clinton's 1993-94 Health Security Act had collapsed politically. John McCain's 2008 campaign proposed replacing the employer-coverage tax exclusion with universal individual tax credits. Progressive Democrats advanced single-payer proposals. The proposal that gained traction came from a different source: the Heritage Foundation's 1989 framework, modified and signed into law in Massachusetts by Republican Governor Mitt Romney in 2006. The Romney-Heritage approach combined three elements — guaranteed issue (no pre-existing-condition denial), individual mandate (everyone must buy coverage), and subsidies (for those who couldn't afford it).

This was, in 1989, a Republican framework designed to be a market-based alternative to single-payer. By 2009, it had become the basis of Barack Obama's Democratic healthcare proposal. The political alchemy of that transformation — and the bitter Republican opposition that ensued, with Romney himself eventually distancing from his own policy lineage — is one of the most studied political episodes of the era.

Stage 2: Passage (March 2010)

The ACA's congressional path was unusual. The Senate passed its version on Christmas Eve 2009. The House had passed a different version. Normally, the two chambers would have negotiated a conference-committee bill. But Senator Edward Kennedy died in August 2009, and his Senate seat was won by Republican Scott Brown in a special election in January 2010 — eliminating the Democratic 60-vote supermajority needed to pass a conference bill. House Speaker Nancy Pelosi made the decision to pass the Senate bill as written, with subsequent fixes done through reconciliation (which requires only 51 Senate votes). The bill passed the House 219-212, with no Republican votes and 34 Democratic defections. The final reconciliation bill passed the Senate 56-43.

The political cost was severe. The 2010 midterm elections produced a Republican wave (the largest seat swing since 1948), with the ACA — and its tortured, line-by-line process — featuring centrally in the Republican campaign.

The bill's structure was exactly the Romney-Heritage three-legged stool: guaranteed issue (Title I, insurance-market reforms), individual mandate (Section 1501), and subsidies (premium tax credits and cost-sharing reductions through Section 1401-1402). It also included the Medicaid expansion (Section 2001), creating a near-universal coverage floor for adults up to 138 percent of FPL.

Stage 3: NFIB v. Sebelius (2012)

The constitutional challenge came in National Federation of Independent Business v. Sebelius, decided June 28, 2012. Twenty-six states, the NFIB, and individual plaintiffs challenged the law on two main grounds: that the individual mandate exceeded Congress's commerce-clause power, and that the Medicaid expansion was unconstitutionally coercive.

Chief Justice John Roberts wrote the controlling opinion. On the mandate, Roberts agreed with the conservative wing that the Commerce Clause did not authorize Congress to compel commerce that did not exist (the "inactivity" of failing to buy insurance). But he then found that the mandate could be sustained as an exercise of Congress's taxing power: the penalty functioned like a tax, was administered by the IRS, and produced revenue. On the tax theory, the mandate survived.

On the Medicaid expansion, Roberts (joined by a different majority including Justices Breyer and Kagan along with the conservative wing) held that conditioning all existing Medicaid funding on a state's adoption of the expansion was unconstitutionally coercive — "a gun to the head" of the states. The expansion had to be made optional. States could decline to expand, retaining their pre-ACA Medicaid funding even if they chose not to expand to the new ACA-eligible population.

The ruling reshaped the law's federalism. Twenty-four states initially declined expansion. Over the next decade, additional states adopted expansion incrementally — through legislative action, ballot initiatives (Maine 2017, Idaho/Nebraska/Utah 2018, Missouri/Oklahoma 2020), and gubernatorial decisions. By 2025, 41 states plus the District of Columbia had expanded; the holdouts (clustered in the South) created an estimated two-million-person coverage gap.

Stage 4: Implementation and exchanges (2013-2017)

The exchanges launched October 1, 2013. Healthcare.gov's notorious initial breakdown — the federal exchange was unusable for the first six weeks — became a synecdoche for the implementation challenge. By March 2014, however, enrollment had reached 8 million, exceeding initial CBO projections. Subsequent enrollment grew to roughly 11.4 million by 2016.

The Medicaid expansion in adopting states reached an additional ~12 million enrollees by 2016. The total ACA coverage gain — exchanges plus Medicaid expansion plus dependent-coverage extensions on parents' plans plus other smaller channels — reached roughly 20 million people by the late 2010s.

Republican efforts to repeal the law continued throughout the implementation period. The House voted to repeal or partially defund the ACA more than 60 times between 2011 and 2016, with each effort dying in the Senate or facing presidential veto. With Republican control of both chambers and the White House in 2017, repeal seemed within reach.

Stage 5: The 2017 repeal effort and mandate zeroing

The 2017 repeal effort proceeded in stages. The House passed the American Health Care Act in May 2017. The Senate considered multiple versions through summer. The decisive moment came on July 28, 2017, when Senator John McCain — recently diagnosed with brain cancer — joined Senators Susan Collins and Lisa Murkowski to defeat the "skinny repeal" bill on a 49-51 vote, with McCain's televised thumbs-down on the Senate floor.

What survived as health-policy change in 2017 was narrower: the Tax Cuts and Jobs Act, signed in December 2017, zeroed the individual-mandate penalty (effective 2019) without otherwise altering the ACA's structure. With no penalty, the mandate was effectively neutralized.

Predictions about market collapse following mandate zeroing were widespread but largely did not materialize. Premiums rose in the post-2017 period, but enrollment remained relatively stable. The reasons are multiple: subsidy generosity absorbed much of the adverse-selection pressure for subsidized enrollees; insurer participation stabilized after early-year exits; state-level mandates in some states (Massachusetts, New Jersey, California, others) substituted for the federal mandate.

Stage 6: California v. Texas (2021)

A subsequent challenge to the entire ACA — California v. Texas — argued that with the mandate penalty zeroed, the law no longer rested on the tax-power justification, and the mandate was unconstitutional; and that the entire ACA was inseverable from the mandate, so the whole law had to fall. The Supreme Court rejected the challenge 7-2 on June 17, 2021, on standing grounds. The plaintiffs had not shown injury from a mandate that imposed no penalty.

The decision effectively ended the era of major existential litigation against the ACA. Subsequent litigation has been around the edges — disputed cost-sharing-reduction payments, religious exemptions for contraceptive coverage, drug-pricing implementation — rather than the law's core.

Stage 7: ARPA / IRA enhancement (2021-2022)

The American Rescue Plan Act of 2021 substantially enhanced ACA premium subsidies for two years. The Inflation Reduction Act of 2022 extended that enhancement through 2025. Under the enhanced subsidies: no enrollee pays more than 8.5 percent of income for benchmark-plan coverage; subsidy eligibility extends above 400 percent of FPL (eliminating the "subsidy cliff"); and premium tax credits are more generous for lower-income enrollees.

Enrollment grew dramatically in response. Marketplace enrollment reached roughly 21 million by the 2024 open enrollment period — nearly double the pre-ARPA peak.

The IRA also added Medicare drug-pricing reforms: capping out-of-pocket Medicare drug spending at $2,000 per year (effective 2025), capping insulin at $35 per month for Medicare beneficiaries, and authorizing Medicare to negotiate prices for a limited set of high-cost drugs (10 in the first round, expanding over time).

Stage 8: The 2026 status and future

As of early 2026, the ACA's coverage architecture is politically settled. Republican efforts to fully repeal have ended. Both parties accept the exchanges, the Medicaid expansion (where adopted), and the basic insurance-market rules.

The fights are at the margins. The enhanced subsidies are scheduled to expire at the end of 2025; their extension is one of the central healthcare-policy questions of the 2026 Congress. Republican positions generally favor allowing the enhancements to expire (returning to the pre-ARPA subsidy structure as a matter of fiscal discipline); Democratic positions favor permanent extension. Drug-pricing implementation under the IRA continues to expand and continues to face industry litigation.

What the empirical record shows

After fifteen years, the data are clearer than the rhetoric.

Coverage: ~20 million previously uninsured Americans gained coverage; the uninsured rate fell from ~16 percent in 2010 to ~8 percent in 2024. This is the law's clear empirical success.

Cost: mixed. The law was sold as "bending the cost curve." Healthcare-cost growth slowed during the law's early years, but most analysts attribute the slowdown to the recession and recovery dynamics, not to the law itself. Cost growth resumed in the late 2010s and continues to outpace overall economic growth. The ACA expanded coverage within an existing high-cost system.

Health outcomes: the strongest evidence comes from comparing Medicaid expansion to non-expansion states. Studies find roughly 4 to 6 percent reductions in mortality among newly Medicaid-eligible adults, with stronger effects for chronic-disease-related deaths. Effects on the broader exchange population are weaker but generally positive on financial security and self-reported health.

Political: the law has survived three serious existential threats (NFIB, the 2017 repeal effort, California v. Texas) and emerged politically stronger after each. The political coalition for repeal has narrowed substantially.

What this case shows about American policy-making

Three lessons stand out.

First, major American social legislation almost always emerges through compromise architectures that draw from multiple political traditions. The ACA's three-legged stool was a Republican-tradition design enacted by Democrats, and it remained recognizable as such even as it became a partisan flashpoint.

Second, judicial review is a real constraint on policy design. NFIB substantially restructured the law's federalism reach in ways that affect millions of Americans annually (the coverage gap in non-expansion states). The Supreme Court is part of the policy-making system, not external to it.

Third, political settlements take time. The ACA was bitterly contested for a decade after passage. By the time the third existential challenge failed in 2021, the political ground had shifted; what could not be repealed was eventually accepted. Major American policy reforms tend to either fail outright or take a decade-plus to settle. Patience with that timeline is an underrated political resource.

The next case study turns to a much faster experiment, with a much faster political verdict: the 2021 expanded Child Tax Credit.